Coalesce

Cambridge, United Kingdom Founded: 2009 • Age: 17 yrs Acquired By Sandoz
Developer of inhalation devices

About Coalesce

Coalesce is a Healthcare company based in Cambridge (United Kingdom) founded in 2009 by Dave Ahern, and was acquired by Sandoz in March 2022. Developer of inhalation devices. The company has 19 employees. Its chief executive, as recorded, is Dave Ahern. The company was acqui-hired. Its focus areas include Life Sciences, Drug Delivery and Inhaled. Its legal entity is COALESCE PRODUCT DEVELOPMENT LIMITED.

Company details

Coalesce was founded in 2009 in Cambridge, United Kingdom, and operates in the medical devices sector. Inhalation devices such as pressurized metered dose inhalers, breath-actuated inhalers, and pre-metered dry powder inhalers are developed by the company. Each device features a substitutable user interface. Focus is placed on innovative delivery systems for respiratory treatments, with operations centered in the UK.

  • Headquarters Cambridge, United Kingdom
  • Employees 19
  • Founders Dave Ahern
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website coalesce.co.uk
  • Social LinkedIn X
  • Acquired by Sandoz (Mar 2022)
  • Legal Name Coalesce Product Development Limited
  • Date of Incorporation 29 May, 2009
  • Jurisdiction LONDON
Key Metrics

Investors in Coalesce

Coalesce has secured backing from 1 investor. Prominent investors backing the company include Sandoz.

All
InvestorDescriptionFounded YearDomainLocation
Generic and biosimilar pharmaceuticals are developed and distributed globally.
1886sandoz.comHolzkirchen, Germany
Premium access

Investor details for Coalesce

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Coalesce

1 people are tracked at Coalesce (1 in leadership); the tracked headcount is 19.

NameRoleGroup
Dave Ahern
Founder & CEOLeadership
Premium access

Complete people profiles for Coalesce

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Coalesce

2 dated milestones of Coalesce across 13 years, from founding to its latest funding, stage changes and deals.

  1. Founded Coalesce is founded.
  2. Exit Acquired by Sandoz.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Coalesce

Premium access

Complete news archive for Coalesce

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Coalesce

Coalesce was founded in 2009.

Coalesce is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.

Dave Ahern is the CEO of Coalesce, as recorded in our data. They have also founded this company.

Coalesce has 19 employees.

Coalesce was founded in 2009 in Cambridge, United Kingdom, and operates in the medical devices sector. Inhalation devices such as pressurized metered dose inhalers, breath-actuated inhalers, and pre-metered dry powder inhalers are developed by the company. Each device features a substitutable user interface. Focus is placed on innovative delivery systems for respiratory treatments, with operations centered in the UK.

Coalesce has 1 investor. Key investors include Sandoz.

Coalesce operates through Coalesce Product Development Limited.

Yes. Coalesce was acquired by Sandoz in March 2022.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available